| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.66T | 2.07B | 1.86B | 1.62B | 1.26B | 1.18B |
| Gross Profit | 1.62T | 416.77M | 356.83M | 335.97M | 182.01M | 158.58M |
| EBITDA | 313.65M | 315.48M | 324.26M | 233.76M | 159.43M | 165.14M |
| Net Income | 27.26M | -37.81M | -71.47M | -81.30M | -47.79M | 2.16M |
Balance Sheet | ||||||
| Total Assets | 4.77B | 4.49B | 4.58B | 4.79B | 4.58B | 3.23B |
| Cash, Cash Equivalents and Short-Term Investments | 147.36M | 76.70M | 43.45M | 65.05M | 81.60M | 113.21M |
| Total Debt | 0.00 | 1.87B | 3.02B | 2.83B | 2.50B | 1.88B |
| Total Liabilities | 2.05B | 2.18B | 3.12B | 3.14B | 2.75B | 2.16B |
| Stockholders Equity | 2.68B | 2.26B | 1.27B | 1.40B | 1.58B | 866.11M |
Cash Flow | ||||||
| Free Cash Flow | 269.10M | 84.15M | -1.26M | 76.25M | -61.78M | 90.85M |
| Operating Cash Flow | 298.79M | 176.09M | 98.53M | 147.77M | 17.91M | 219.16M |
| Investing Cash Flow | -286.11M | -8.73M | 9.40M | -118.58M | -138.65M | -147.94M |
| Financing Cash Flow | -139.98M | -134.74M | -129.06M | -42.92M | 94.11M | -8.81M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $7.94B | 26.50 | 8.13% | 3.58% | 59.25% | 88.37% | |
76 Outperform | $12.60B | 23.95 | 11.28% | 6.16% | 13.50% | 31.56% | |
75 Outperform | $3.58B | 24.05 | 10.87% | 4.81% | 8.04% | 9.20% | |
74 Outperform | $4.70B | 25.92 | 6.29% | 6.59% | 8.12% | 75.95% | |
70 Neutral | $8.17B | 340.34 | 1.12% | 2.02% | 11.80% | ― | |
65 Neutral | $2.17B | 12.19 | 3.79% | 4.94% | 3.15% | 1.96% | |
57 Neutral | $6.30B | ― | -7.26% | 6.59% | -6.59% | 33.35% |
American Healthcare REIT, Inc. is a real estate investment trust that acquires, owns, and operates a diversified portfolio of clinical healthcare real estate, focusing primarily on senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, the United Kingdom, and the Isle of Man.
On November 6, 2025, American Healthcare REIT, Inc. announced its third quarter 2025 results, highlighting a GAAP net income of $55.9 million and a 16.4% growth in Same-Store Net Operating Income compared to the same period in 2024. The company also reported significant acquisition activity, closing over $575 million in new acquisitions year-to-date, and increased its full-year 2025 guidance due to strong performance in its senior housing and integrated senior health campuses segments. The announcement reflects the company’s strategic growth and favorable market conditions, positioning it well for continued expansion and stakeholder value enhancement.
The most recent analyst rating on (AHR) stock is a Hold with a $51.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.
On September 18, 2025, American Healthcare REIT, Inc. announced a quarterly distribution of $0.25 per share for the third quarter of 2025, covering the period from July 1 to September 30. This distribution, equating to an annualized rate of $1.00 per share, will be paid in cash on or about October 17, 2025, to stockholders of record as of September 30, 2025. This announcement reflects the company’s ongoing commitment to providing returns to its investors and may influence its market positioning within the healthcare real estate sector.
The most recent analyst rating on (AHR) stock is a Buy with a $48.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.
American Healthcare REIT, Inc. recently held its earnings call, revealing a generally positive sentiment characterized by strong financial performance. The company reported significant same-store NOI growth, successful acquisitions, and improved leverage metrics. Noteworthy achievements include obtaining the Great Place to Work Certification and increasing Medicare Advantage concentration. Despite these positives, challenges were noted in the outpatient medical segment and the complexities of navigating fragmented Medicare Advantage contracts. Overall, the positive aspects of the earnings call significantly outweighed the challenges.
American Healthcare REIT, Inc. faces significant business risks due to potential legislative changes at federal, state, or local levels that could restrict their investment opportunities in healthcare real estate. The enactment of the One Big Beautiful Bill Act (OBBBA) on July 4, 2025, by President Trump, introduces substantial alterations to U.S. federal income tax laws, including permanent extensions of certain provisions from the Tax Cuts and Jobs Act of 2017. While these changes offer some benefits, such as a higher percentage limit for taxable REIT subsidiaries, the $1 trillion cuts to Medicaid spending could negatively affect the financial performance of healthcare providers, thereby impacting the REIT’s investment returns. Consequently, these regulatory shifts present a material adverse risk to the company’s business operations and investment strategies.
American Healthcare REIT, Inc. (NYSE: AHR) is a real estate investment trust that focuses on acquiring, owning, and operating a diversified portfolio of clinical healthcare real estate, including senior housing communities, skilled nursing facilities, and outpatient medical buildings across the United States, the United Kingdom, and the Isle of Man.
On August 8, 2025, American Healthcare REIT, Inc. entered into a new ATM Equity Offering Sales Agreement with several financial institutions, allowing for the sale of up to $1 billion in common stock. This agreement replaces a prior offering program and aims to provide flexibility in raising capital based on market conditions and company needs, potentially impacting the company’s financial strategy and market presence.
The most recent analyst rating on (AHR) stock is a Buy with a $28.00 price target. To see the full list of analyst forecasts on American Healthcare REIT, Inc. stock, see the AHR Stock Forecast page.